BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8080674)

  • 41. [Tropisetron for the prevention of nausea and vomiting during chemotherapy: multicenter clinical study].
    Gutiérrez J; Bronfman L; Cao C; Vásquez A; Derio L; Rosas J; del Castillo C; Yáñez M; Fodor M; Gallardo J; Cerda B; Torres R; Orlandi L; Orlandi F; Kleinman S; Vogel C
    Rev Med Chil; 1996 Aug; 124(8):967-74. PubMed ID: 9196997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Gershanovich M; Kolygin B; Pirgach N
    Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Yarker YE; McTavish D
    Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
    Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
    Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy.
    Falkson CI; Falkson HC
    Oncology; 1995; 52(5):427-31. PubMed ID: 7637962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.
    Herrstedt J; Sigsgaard TC; Nielsen HA; Handberg J; Langer SW; Ottesen S; Dombernowsky P
    Support Care Cancer; 2007 Apr; 15(4):417-26. PubMed ID: 17093916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapy.
    du Bois A; McKenna CJ; Andersson H; Lahousen M; Kitchener H; Pinter T; Capstick V; Wilkinson JR
    Oncology; 1997; 54(1):7-14. PubMed ID: 8978585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.
    Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
    Drugs; 1992; 43 Suppl 3():27-32. PubMed ID: 1380430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
    Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
    Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
    Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
    Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis.
    Garcia-del-Muro X; Vadell C; Pérez Manga G; Bover I; Rifá J; Beltrán M; Barros MM; Germá JR; Fabregat X; Moreno V; Salvador A; Viladiu P
    Eur J Cancer; 1998 Jan; 34(1):193-5. PubMed ID: 9624257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compassionate use of tropisetron in patients at high risk of severe emesis.
    Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
    Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.
    Van Belle SJ; Stamatakis L; Bleiberg H; Cocquyt VF; Michel J; de Bruijn KM
    Ann Oncol; 1994 Nov; 5(9):821-5. PubMed ID: 7848884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.